These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 28931314)
1. The diagnostic potential of mutation detection from single circulating tumor cells in cancer patients. Salvianti F; Pinzani P Expert Rev Mol Diagn; 2017 Nov; 17(11):975-981. PubMed ID: 28931314 [TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer. De Luca F; Rotunno G; Salvianti F; Galardi F; Pestrin M; Gabellini S; Simi L; Mancini I; Vannucchi AM; Pazzagli M; Di Leo A; Pinzani P Oncotarget; 2016 May; 7(18):26107-19. PubMed ID: 27034166 [TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of circulating tumor cells-from bench to bedside. Li Y; Wu S; Bai F Semin Cell Dev Biol; 2018 Mar; 75():88-97. PubMed ID: 28899718 [TBL] [Abstract][Full Text] [Related]
4. Next-generation Sequencing (NGS) Analysis on Single Circulating Tumor Cells (CTCs) with No Need of Whole-genome Amplification (WGA). Palmirotta R; Lovero D; Silvestris E; Felici C; Quaresmini D; Cafforio P; Silvestris F Cancer Genomics Proteomics; 2017; 14(3):173-179. PubMed ID: 28446532 [TBL] [Abstract][Full Text] [Related]
5. Reality of Single Circulating Tumor Cell Sequencing for Molecular Diagnostics in Pancreatic Cancer. Court CM; Ankeny JS; Sho S; Hou S; Li Q; Hsieh C; Song M; Liao X; Rochefort MM; Wainberg ZA; Graeber TG; Tseng HR; Tomlinson JS J Mol Diagn; 2016 Sep; 18(5):688-696. PubMed ID: 27375074 [TBL] [Abstract][Full Text] [Related]
6. A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer. Jiang R; Lu YT; Ho H; Li B; Chen JF; Lin M; Li F; Wu K; Wu H; Lichterman J; Wan H; Lu CL; OuYang W; Ni M; Wang L; Li G; Lee T; Zhang X; Yang J; Rettig M; Chung LW; Yang H; Li KC; Hou Y; Tseng HR; Hou S; Xu X; Wang J; Posadas EM Oncotarget; 2015 Dec; 6(42):44781-93. PubMed ID: 26575023 [TBL] [Abstract][Full Text] [Related]
8. Single-cell analysis of CTCs with diagnostic precision: opportunities and challenges for personalized medicine. Alberter B; Klein CA; Polzer B Expert Rev Mol Diagn; 2016; 16(1):25-38. PubMed ID: 26567956 [TBL] [Abstract][Full Text] [Related]
9. Precision oncology using a limited number of cells: optimization of whole genome amplification products for sequencing applications. Sho S; Court CM; Winograd P; Lee S; Hou S; Graeber TG; Tseng HR; Tomlinson JS BMC Cancer; 2017 Jul; 17(1):457. PubMed ID: 28666423 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the liquid biopsy for the detection of BRAFV600E mutation in metastatic melanoma patients. Salvianti F; Massi D; De Giorgi V; Gori A; Pazzagli M; Pinzani P Cancer Biomark; 2019; 26(3):271-279. PubMed ID: 31524142 [TBL] [Abstract][Full Text] [Related]
11. Single circulating tumor cell sequencing as an advanced tool in cancer management. Salvianti F; Pazzagli M; Pinzani P Expert Rev Mol Diagn; 2016; 16(1):51-63. PubMed ID: 26560087 [TBL] [Abstract][Full Text] [Related]
12. [Single-cell detection of EGFR gene mutation in circulating tumor cells in lung cancer]. Sun S; Deng YL Yi Chuan; 2015 Dec; 37(12):1251-7. PubMed ID: 26704950 [TBL] [Abstract][Full Text] [Related]
13. Circulating cell-free DNA and circulating tumor cells, the "liquid biopsies" in ovarian cancer. Cheng X; Zhang L; Chen Y; Qing C J Ovarian Res; 2017 Nov; 10(1):75. PubMed ID: 29132396 [TBL] [Abstract][Full Text] [Related]
14. Single-Circulating Tumor Cell Whole Genome Amplification to Unravel Cancer Heterogeneity and Actionable Biomarkers. Khan T; Becker TM; Po JW; Chua W; Ma Y Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955517 [TBL] [Abstract][Full Text] [Related]
15. Genomic Analysis of Circulating Tumor Cells at the Single-Cell Level. Lu S; Chang CJ; Guan Y; Szafer-Glusman E; Punnoose E; Do A; Suttmann B; Gagnon R; Rodriguez A; Landers M; Spoerke J; Lackner MR; Xiao W; Wang Y J Mol Diagn; 2020 Jun; 22(6):770-781. PubMed ID: 32247862 [TBL] [Abstract][Full Text] [Related]
16. Characterization of single circulating tumor cells. Alix-Panabières C; Pantel K FEBS Lett; 2017 Aug; 591(15):2241-2250. PubMed ID: 28459503 [TBL] [Abstract][Full Text] [Related]
17. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy. Alix-Panabières C; Pantel K Cancer Discov; 2016 May; 6(5):479-91. PubMed ID: 26969689 [TBL] [Abstract][Full Text] [Related]
18. Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer. Kidess-Sigal E; Liu HE; Triboulet MM; Che J; Ramani VC; Visser BC; Poultsides GA; Longacre TA; Marziali A; Vysotskaia V; Wiggin M; Heirich K; Hanft V; Keilholz U; Tinhofer I; Norton JA; Lee M; Sollier-Christen E; Jeffrey SS Oncotarget; 2016 Dec; 7(51):85349-85364. PubMed ID: 27863403 [TBL] [Abstract][Full Text] [Related]
19. Isolation and genome sequencing of individual circulating tumor cells using hydrogel encapsulation and laser capture microdissection. Park ES; Yan JP; Ang RA; Lee JH; Deng X; Duffy SP; Beja K; Annala M; Black PC; Chi KN; Wyatt AW; Ma H Lab Chip; 2018 Jun; 18(12):1736-1749. PubMed ID: 29762619 [TBL] [Abstract][Full Text] [Related]
20. Advances in liquid biopsy using circulating tumor cells and circulating cell-free tumor DNA for detection and monitoring of breast cancer. Zhang X; Ju S; Wang X; Cong H Clin Exp Med; 2019 Aug; 19(3):271-279. PubMed ID: 31190187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]